Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Agennix, Inc.
Other
Array BioPharma Inc.
Other
BioVex, Inc. (subsidiary of Amgen)
Other
Caladrius Biosciences
Other
Eisai Inc.
Other
Genentech, Inc.
Other
Genta, Inc.
Other
Iovance Biotherapeutics, Inc
Other
MSD International Business GmbH
Other
MedImmune, LLC
Other
Novartis Pharmaceuticals Corporation
Other
OncoSec Medical Incorporated
Other
Ribi ImmunoChem Research, Inc.
Other
Scancell Ltd.
Other
Xoma Corporation
Other